GWS
ARNA

Glassman Wealth Services’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Glassman Wealth Services’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16
Closed -$1K – 2065
2021
Q4 		$1K Buy
16
+13
+433% +$856 ﹤0.01% 1597
2021
Q3 		$0 Buy
+3
New +$177 ﹤0.01% 1903
2020
Q1 		– Sell
-11
Closed – – 1706
2019
Q4 		$0 Buy
11
+1
+10% +$47 ﹤0.01% 1591
2019
Q3 		$0 Sell
10
-1
-9% -$56 ﹤0.01% 1486
2019
Q2 		$1K Buy
11
+1
+10% +$52 ﹤0.01% 991
2019
Q1 		$0 Hold
10
– – ﹤0.01% 1254
2018
Q4 		$0 Buy
+10
New +$393 ﹤0.01% 1040

Glassman Wealth Services's ARNA Position: Q1 2022 in Review

Glassman Wealth Services sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 16 shares — an estimated $1K sold.

Glassman Wealth Services first reported a position in ARNA in Q4 2018 and held it in 7 quarters. The position peaked at $1K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Glassman Wealth Services reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 16 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1K.
  • Glassman Wealth Services first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 7 quarters.
  • Glassman Wealth Services's Arena Pharmaceuticals Inc position peaked at $1K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Glassman Wealth Services's 13F filing for Q1 2022, filed 14 Apr 2022.